Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6132228

COC(=O)c1ccc(-c2ccc(N3CCNCC3)cc2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
USP2 O75604 1/20 0.50
TSHR P16473 1/20 0.50
HSD17B10 Q99714 1/20 0.50
OPRD1 P41143 1/20 0.48
MAOB P27338 2/20 0.46
ACVR1 Q04771 1/20 0.45
CTSK P43235 2/20 0.44
HTR3E A5X5Y0 1/20 0.44
HTR3B O95264 1/20 0.44
ADRB1 P08588 1/20 0.44
HTR3A P46098 1/20 0.44
HTR3D Q70Z44 1/20 0.44
HTR3C Q8WXA8 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
MAPKAPK2 P49137 2/20 0.44
CTSL P07711 3/20 0.44
CTSB P07858 2/20 0.44
CTSS P25774 2/20 0.44
PKM P14618 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL532602 0.87 ALDH1A1 (0.65) ALDH1A1USP2TSHRHSD17B10OPRD1
Hydrochloric Acid SCHEMBL28823824 0.85 ALDH1A1 (0.63) ALDH1A1USP2TSHRHSD17B10OPRD1
Trifluoroacetic Acid SCHEMBL5265518 0.83 USP2 (0.59) ALDH1A1USP2TSHRHSD17B10ACVR1
Trifluoroacetic Acid SCHEMBL25313166 0.81 TSHR (0.49) ALDH1A1USP2TSHRHSD17B10OPRD1
Trifluoroacetic Acid SCHEMBL6392063 0.79 ALDH1A1 (0.57) ALDH1A1USP2TSHRHSD17B10OPRD1
Tert-Butyl Formate SCHEMBL27908417 0.79 ALDH1A1 (0.52) ALDH1A1USP2TSHRHSD17B10OPRD1
Trifluoroacetic Acid SCHEMBL6336692 0.78 ADRB1 (0.69) ALDH1A1USP2TSHRHSD17B10MAOB
SCHEMBL27821389 0.78 ALDH1A1 (0.54) ALDH1A1USP2TSHRHSD17B10OPRD1
Trifluoroacetic Acid SCHEMBL15842089 0.77 GCK (0.49) ALDH1A1USP2TSHRHSD17B10MAOB
Trifluoroacetic Acid SCHEMBL29803762 0.77 RAB9A (0.56) ALDH1A1USP2TSHRHSD17B10MAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6884774-B2 Cyclic hexapeptide derivatives FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2005-04-26 US disclosed
EP-1259535-B1 CYCLIC HEXAPEPTIDE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-04-13 EP disclosed
US-20030083238-A1 Cyclic hexapeptide derivatives ASTELLAS PHARMA INC. (JP) 2003-05-01 US disclosed
EP-1259535-A1 CYCLIC HEXAPEPTIDE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-11-27 EP disclosed
WO-2001060846-A1 CYCLIC HEXAPEPTIDE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030083238-A1 Cyclic hexapeptide derivatives NGLY1, ALG1, CHIT1 ALDH1A1 4718/4885USP2 4462/4885TSHR 3037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.